CG Health Ventures

CG Health Ventures is a healthcare-focused investor with a public footprint that includes LinkedIn and Crunchbase but limited public disclosure of thesis specifics, fund size, or geographic focus. The ‘Health Ventures’ framing signals a healthcare-specialist mandate, which is a meaningful signal for founders: they are presumably more knowledgeable about clinical, regulatory, and commercial dynamics than a generalist fund of similar size. For healthcare AI founders, CG Health Ventures is most plausibly relevant at the seed and Series A stages, with check sizes likely $250K to $2M, deployed alongside a primary-led round or as a co-lead in smaller deals. Stage focus is most plausibly seed through early Series A based on the small-fund footprint. Founders who should approach: clinical AI, digital health, and healthcare services teams looking for a domain-aware co-investor that can speak fluently to provider, payer, and pilot dynamics; founders raising rounds where adding a healthcare-specialist name to the cap table sharpens the syndicate narrative. Founders who should not approach: those needing very large checks, biotech requiring specialist therapeutics syndicates, and consumer-only health apps without a clear B2B story. The realistic entry path is warm introduction through their existing portfolio or co-investors active in healthcare seed syndicates; LinkedIn outreach to specific partners is reasonable. Before investing significant time, ask the introducer about their typical check size, recent deals, and stage discipline. Treat CG Health Ventures as a useful domain-aware co-investor rather than a category-defining lead, and structure your fundraising calendar accordingly.